
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TLE2 CRISPR/Cas9 KO Plasmid (m) | sc-423413 | 20 µg | $397.00 |
Tle2 encodes the transcriptional corepressor TLE2, a Groucho/TLE family protein that scaffolds repressive chromatin complexes to modulate context-dependent gene expression programs during development and tissue homeostasis. TLE2 interacts with sequence-specific transcription factors and integrates signals from pathways including Wnt/β-catenin and Notch, shaping cell fate decisions, differentiation, and stem/progenitor maintenance. In mouse models and cellular systems, altered TLE2 activity can perturb lineage specification and proliferative control, making it relevant for studying mechanisms underlying dysregulated transcriptional networks in developmental disorders and cancer-associated pathways. Its nuclear corepressor functions also position it as a useful node for dissecting epigenetic regulation and transcriptional repression dynamics.
TLE2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tle2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Tle2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Tle2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish TLE2 protein expression.
This CRISPR knockout system enables efficient generation of Tle2-deficient cell models for investigation of TLE2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.